ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Tasigna 50 mg, Kapseln - 120
58007005 Novartis Pharma Schweiz AG
Tasigna 50 mg, Kapseln24.07.2007
  31.01.2018
Nilotinib (L01EA03) 
WHO-DDD 
07.16.10.120
07.16.10. 
A  
No 
IP 
PR  
k.A.PR
  
7680580070056Synthetika
  
Composition
nilotinibum 50 mg ut nilotinibi hydrochloridum monohydricum, lactosum monohydricum 39.025 mg, crospovidonum, poloxamerum, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula.
Packungsbestandteile
Capsules
 
Active AgentDose
Nilotinibum50 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum)  
(Rubrum)  
Ammoniae Solutio28  
Crospovidonum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Lacca Drucktinte
Lactose Monohydrate39.025 mg 
Magnesii Stearas  
Per Centum  
Poloxamer  
Pro Capsula  
Propylenglycol  
Silica Colloidalis Anhydrica  
Source
Data was imported : 04.12.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home